10% Owner RTW Buys $6M of Orchestra BioMed Stock at the $5.00 Offering Price
OBIO sits 80% above its 52-week low of $3.46.
Summary
RTW Investments bought 1.2 million Orchestra BioMed shares at $5.00 for $6 million on 2026-11-09, lifting its stake to 10.76 million shares. The purchase came at the same price as the company's just-closed $86.3M offering.
Key Events · Ownership and Investor Activity · OBIO
-
RTW Buys 1.2M Shares for $6M
RTW Investments, LP and Roderick Wong reported an open-market purchase of 1,200,000 shares at $5.00 on 2026-11-09, a $6,000,000 transaction.
-
Stake Rises to 10.76M Shares
Post-transaction holdings total 10,756,063 shares, held indirectly through affiliated RTW funds.
-
Priced at Offering Level
The $5.00 purchase price matches the price of the underwritten offering that closed 2026-11-09, raising about $86.3 million gross.
-
Follows Discounted Raise
The offering was priced below the $5.62 last sale, and RTW's buying at that level absorbs part of the new supply.
Analysis · OBIO · Industrial Applications And Services
RTW Investments, the largest outside holder, put $6 million of fresh money into Orchestra BioMed at $5.00 a share — the exact price of the $86.3M offering that closed on 2026-11-09. This is real cash, not an option exercise, and it absorbs a meaningful slice of the newly issued stock. Because the purchase is a 10% owner's allocation rather than an operating executive's bet, it says more about institutional demand for the deal than about day-to-day execution. Still, a holder adding at the deal price right after a discounted raise is a supportive read on the equity story.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OBIO was trading at $6.23 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $484M. The 52-week trading range was $3.46 to $6.50. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.